These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 55535)

  • 1. Hyperprolactinaemia and luteal insufficiency.
    Seppälä M; Ranta T; Hirvonen E
    Lancet; 1976 Jan; 1(7953):229-30. PubMed ID: 55535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine treatment of secondary amenorrhoea.
    Seppalå M; Hirvonen E; Ranta T
    Lancet; 1976 May; 1(7970):1154-6. PubMed ID: 58200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of bromocriptine in hyperprolactinaemic anovulation and related disorders.
    Franks S
    Drugs; 1979 May; 17(5):337-48. PubMed ID: 378649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent bromocriptine treatment for the induction of ovulation in hyperprolactinemic patients.
    Bennink HJ
    Fertil Steril; 1979 Mar; 31(3):267-72. PubMed ID: 571359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocryptine therapy in luteal insufficiency.
    Godó G; Sas M; Falkay G
    Acta Med Acad Sci Hung; 1980; 37(3):283-8. PubMed ID: 7192924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin levels and bromocriptine treatment of short luteal phase.
    Lehtovirta P; Arjomaa P; Ranta T; Laatikainen T; Hirvonen E; Seppälä M
    Int J Fertil; 1979; 24(1):57-60. PubMed ID: 37181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metergoline as an alternative to bromocriptine in amenorrhoea.
    Hicks BH; Finer N; Herbert LC
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):439-44. PubMed ID: 6440388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
    Mroueh AM; Siler-Khodr TM
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovulation and normal luteal function during LHRH treatment of women with hyperprolactinaemic amenorrhoea.
    Polson DW; Sagle M; Mason HD; Adams J; Jacobs HS; Franks S
    Clin Endocrinol (Oxf); 1986 May; 24(5):531-7. PubMed ID: 3539412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menstrual function and serum prolactin levels after long-term bromocriptine treatment of hyperprolactinaemic amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1982 Jun; 16(6):587-93. PubMed ID: 7105430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and significance of hyperprolactinaemia in women with amenorrhea.
    Franks S; Murray MA; Jequier AM; Steele SJ; Nabarro JD; Jacobs HS
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):597-607. PubMed ID: 1104218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
    Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy following metergoline treatment in a patient with hyperprolactinaemia.
    Crosignani PG; Reschini E; Peracchi M; D'Alberton A; Lombroso GC
    Br J Obstet Gynaecol; 1977 May; 84(5):386-8. PubMed ID: 889732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raised serum PRL and androgen levels associated with hyrsutism, amenorrhoea and galactorrhoea.
    Malato M
    Acta Eur Fertil; 1978 Dec; 9(4):175-83. PubMed ID: 573041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
    Künzig HJ; Geiger W; Schulz KD; Lose KH
    Arch Gynakol; 1975; 218(2):85-94. PubMed ID: 1174026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of amenorrhoea, galactorrhoea and hypogonadism with bromocriptine.
    Donald RA; Espiner EA; Livesey JH
    Aust N Z J Med; 1978 Jun; 8(3):262-6. PubMed ID: 279321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of luteal phase inadequacy with bromocriptine.
    Saunders DM; Hunter JC; Haase HR; Wilson GR
    Obstet Gynecol; 1979 Mar; 53(3):287-9. PubMed ID: 424098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of menstruation with bromocryptine in patients with euprolactinemic amenorrhea.
    Tolis G; Naftolin F
    Am J Obstet Gynecol; 1976 Oct; 126(4):426-9. PubMed ID: 990045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.